Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CAR-T To Go: Juno Sees JCAR017 As Safer, Suited For Outpatients

Nov 03 2017

3d illustration of T cells or cancer cells

Related Content

Juno Ends JCAR015 Development In ALL, Cementing Third Place CAR-T Position

Mar 02 2017

Novartis Beats CAR-T Competitors To The Pricing Punch With Kymriah Approval

Aug 31 2017

Gilead/Kite Pricing For Yescarta Undercuts Novartis's CAR-T Kymriah

Oct 19 2017

Related Companies

Bristol Myers Squibb Company

Novartis AG

Kite Pharma, Inc.

Gilead Sciences, Inc.

Roche Holding AG

Additional Topics

ImmunoOncology Sales & Earnings Market Intelligence Research & Development Cancer BioPharmaceutical

More from Immuno-oncology

More from Anticancer

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window